Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC ...
On June 22, Truist raised its price target on Progyny, Inc. (NASDAQ:PGNY) to $33 from $30 while maintaining a Buy rating ...
Progyny, Inc. (NASDAQ:PGNY) reported worse-than-expected third-quarter sales results and issued FY24 revenue guidance below estimates. Progyny reported quarterly earnings of 11 cents per share which ...
Hosted on MSN
NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer ...
NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that ...
Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended March 31, 2026, after the close of the ...
Progyny, Inc. recently held its earnings call, revealing a generally positive sentiment despite a few challenges. The company reported strong performance with revenue and profitability surpassing ...
Progyny is a company that helps employees of large companies navigate their fertility benefits. It has hired J.P. Morgan as its lead bank ahead of its initial public offering, sources tell CNBC. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results